McKesson Net Change in Property, Plant, and Equipment 2010-2025 | MCK
McKesson annual/quarterly net change in property, plant, and equipment history and growth rate from 2010 to 2025. Net change in property, plant, and equipment can be defined as the overall change in capital expenditures and sales of plant, property and equipment. This field is used if a company does not report separately sales and purchases of plant, property and equipment or is calculated as the sum of purchases and sales of PP&E
- McKesson net change in property, plant, and equipment for the quarter ending March 31, 2025 was $-0.859B, a 25.04% increase year-over-year.
- McKesson net change in property, plant, and equipment for the twelve months ending March 31, 2025 was $-1.992B, a 33.42% increase year-over-year.
- McKesson annual net change in property, plant, and equipment for 2025 was $-0.859B, a 25.04% increase from 2024.
- McKesson annual net change in property, plant, and equipment for 2024 was $-0.687B, a 23.12% increase from 2023.
- McKesson annual net change in property, plant, and equipment for 2023 was $-0.558B, a 4.3% increase from 2022.
McKesson Annual Net Change in Property, Plant, and Equipment
(Millions of US $) |
| 2025 |
$-859 |
| 2024 |
$-687 |
| 2023 |
$-558 |
| 2022 |
$-535 |
| 2021 |
$-641 |
| 2020 |
$-506 |
| 2019 |
$-557 |
| 2018 |
$-580 |
| 2017 |
$-562 |
| 2016 |
$-677 |
| 2015 |
$-545 |
| 2014 |
$-419 |
| 2013 |
$-400 |
| 2012 |
$-398 |
| 2011 |
$-388 |
| 2010 |
$-378 |
| 2009 |
$-392 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$86.017B |
$359.051B |
|
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
|
